Abstract

Background: The utmost goal for any cancer therapy is to enable cancer patients to become cancer free. However, cancer treatments often entail debilitating side effects that impede patients’ ability to adhere to prescribed regimens, potentially compromising therapeutic success. Biophoton co-therapy has emerged as a solution aimed at mitigating these side effects, improving treatment tolerance and enhancing quality of life.
Case presentations: This report details four cases involving diverse cancer types and therapeutic regimens: [1] a 48-year-old Hispanic female with advanced breast and kidney cancers, [2] a 24-year-old Caucasian female with SDH-deficient gastrointestinal stromal tumor, [3] a 62-year-old Caucasian male with recurrent prostate cancer and [4] a 55-year-old Caucasian male with advanced esophageal carcinoma. Each patient integrated biophoton co-therapy with standard cancer treatments, such as chemotherapy, radiotherapy, or targeted therapies. Across all cases, biophoton therapy alleviated pancytopenia, fatigue, pain and other treatment-related side effects, enabling uninterrupted completion of cancer therapies. Remarkably, three of the four patients achieved cancer-free status with substantial improvements in their overall quality of life.
Conclusion: This case series highlights the potential of biophoton co-therapy as a valuable adjunctive treatment in oncology. By reducing side effects and enhancing treatment adherence, biophoton co-therapy contributes to improved clinical outcomes. These findings emphasize the importance of further research to validate its efficacy and evaluate its integration into standard cancer care protocols.

Keywords:Biophoton therapy; Cancer treatment tolerance; Cancer free; Adjunctive oncology care; Side effect management; Case report